S&P 500   4,080.11
DOW   34,589.77
QQQ   293.36
The AP Interview: IMF head urges China to end mass lockdowns
Without Graphite, There Would Be ZERO EV Batteries! (Ad)
Santa Claus Rally? Here’s What Needs to Happen
25 Ways to Improve Your Financial Situation in 1 Hour
Without Graphite, There Would Be ZERO EV Batteries! (Ad)
Cosmos Holdings May be a Long-Term Buy with Short-Term Risk
Dark Clouds Are Gathering For Cloud Stocks 
Without Graphite, There Would Be ZERO EV Batteries! (Ad)
An inflation gauge closely tracked by the Federal Reserve slowed to a still-high 6% in October
Will Easing Of Covid Rules Slash Risk For Chinese EV Maker NIO?
S&P 500   4,080.11
DOW   34,589.77
QQQ   293.36
The AP Interview: IMF head urges China to end mass lockdowns
Without Graphite, There Would Be ZERO EV Batteries! (Ad)
Santa Claus Rally? Here’s What Needs to Happen
25 Ways to Improve Your Financial Situation in 1 Hour
Without Graphite, There Would Be ZERO EV Batteries! (Ad)
Cosmos Holdings May be a Long-Term Buy with Short-Term Risk
Dark Clouds Are Gathering For Cloud Stocks 
Without Graphite, There Would Be ZERO EV Batteries! (Ad)
An inflation gauge closely tracked by the Federal Reserve slowed to a still-high 6% in October
Will Easing Of Covid Rules Slash Risk For Chinese EV Maker NIO?
S&P 500   4,080.11
DOW   34,589.77
QQQ   293.36
The AP Interview: IMF head urges China to end mass lockdowns
Without Graphite, There Would Be ZERO EV Batteries! (Ad)
Santa Claus Rally? Here’s What Needs to Happen
25 Ways to Improve Your Financial Situation in 1 Hour
Without Graphite, There Would Be ZERO EV Batteries! (Ad)
Cosmos Holdings May be a Long-Term Buy with Short-Term Risk
Dark Clouds Are Gathering For Cloud Stocks 
Without Graphite, There Would Be ZERO EV Batteries! (Ad)
An inflation gauge closely tracked by the Federal Reserve slowed to a still-high 6% in October
Will Easing Of Covid Rules Slash Risk For Chinese EV Maker NIO?
S&P 500   4,080.11
DOW   34,589.77
QQQ   293.36
The AP Interview: IMF head urges China to end mass lockdowns
Without Graphite, There Would Be ZERO EV Batteries! (Ad)
Santa Claus Rally? Here’s What Needs to Happen
25 Ways to Improve Your Financial Situation in 1 Hour
Without Graphite, There Would Be ZERO EV Batteries! (Ad)
Cosmos Holdings May be a Long-Term Buy with Short-Term Risk
Dark Clouds Are Gathering For Cloud Stocks 
Without Graphite, There Would Be ZERO EV Batteries! (Ad)
An inflation gauge closely tracked by the Federal Reserve slowed to a still-high 6% in October
Will Easing Of Covid Rules Slash Risk For Chinese EV Maker NIO?
NYSE:HRC

Hill-Rom - HRC Stock Forecast, Price & News

Notice: This company has been marked as potentially delisted and may not be actively trading.
Add
Compare
Today's Range
$155.96
$155.96
50-Day Range
$155.05
$156.18
52-Week Range
$93.34
$156.22
Volume
N/A
Average Volume
656,912 shs
Market Capitalization
$10.30 billion
P/E Ratio
41.92
Dividend Yield
0.62%
Price Target
N/A
HRC stock logo

About Hill-Rom (NYSE:HRC) Stock

Hill-Rom Holdings, Inc. operates as a medical technology company. The firm focuses on patient care solutions that improve clinical and economic outcomes. It operates through the following segments: Patient Support System, Front Line Care and Surgical Solutions. The Patient Support Systems segment provides bed frames and surfaces, mobility and clinical workflow solutions. The Front Line Care segment offers respiratory care products and sells medical diagnostic equipment and a diversified portfolio of devices. The Surgical Solutions segment supplies surgical products including tables, lights, pendants, positioning devices, various other surgical products and accessories. The company was founded by William A. Hillenbrand on August 7, 1969 and is headquartered in Chicago, IL.

Receive HRC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Hill-Rom and its competitors with MarketBeat's FREE daily newsletter.

HRC Stock News Headlines

See More Headlines

Receive HRC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Hill-Rom and its competitors with MarketBeat's FREE daily newsletter.

HRC Company Calendar

Last Earnings
11/05/2021
Today
12/01/2022
Fiscal Year End
9/30/2023

Industry, Sector and Symbol

Industry
Surgical & Medical Instruments
Sub-Industry
Health Care Equipment
Sector
Medical
CUSIP
43147510
Employees
10,000
Year Founded
N/A

Profitability

Net Income
$248.50 million
Pretax Margin
10.03%

Debt

Sales & Book Value

Annual Sales
$3.02 billion
Cash Flow
$9.29 per share
Book Value
$28.56 per share

Miscellaneous

Free Float
65,594,000
Market Cap
$10.30 billion
Optionable
Optionable
Beta
0.55

Key Executives

  • John P. Groetelaars
    President, Chief Executive Officer & Director
  • Tim Lawrence
    Senior Vice President-Operations
  • Barbara W. Bodem
    Chief Financial Officer & Senior Vice President
  • Brian L. Lawrence
    Chief Technology Officer & SVP-Innovation
  • Ilana Shulman
    Chief Compliance Officer













HRC Stock - Frequently Asked Questions

How were Hill-Rom's earnings last quarter?

Hill-Rom Holdings, Inc. (NYSE:HRC) issued its earnings results on Friday, November, 5th. The medical technology company reported $1.67 earnings per share for the quarter, beating the consensus estimate of $1.47 by $0.20. The medical technology company had revenue of $797.90 million for the quarter, compared to analyst estimates of $752.97 million. Hill-Rom had a net margin of 8.23% and a trailing twelve-month return on equity of 23.07%. The firm's revenue was up 13.1% on a year-over-year basis. During the same period in the previous year, the business earned $1.17 EPS.

Is Hill-Rom a good dividend stock?

Hill-Rom (NYSE:HRC) pays an annual dividend of $0.96 per share and currently has a dividend yield of 0.62%. The company has been increasing its dividend for 11 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio is 25.81%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, HRC will have a dividend payout ratio of 13.37% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for HRC.

What is John P. Groetelaars' approval rating as Hill-Rom's CEO?

54 employees have rated Hill-Rom Chief Executive Officer John P. Groetelaars on Glassdoor.com. John P. Groetelaars has an approval rating of 82% among the company's employees.

What other stocks do shareholders of Hill-Rom own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Hill-Rom investors own include Steel Dynamics (STLD), Walt Disney (DIS), NVIDIA (NVDA), Block (SQ), PayPal (PYPL), Salesforce (CRM), CVS Health (CVS), Micron Technology (MU), AbbVie (ABBV) and Bank of America (BAC).

What is Hill-Rom's stock symbol?

Hill-Rom trades on the New York Stock Exchange (NYSE) under the ticker symbol "HRC."

What is Hill-Rom's stock price today?

One share of HRC stock can currently be purchased for approximately $155.96.

How much money does Hill-Rom make?

Hill-Rom (NYSE:HRC) has a market capitalization of $10.30 billion and generates $3.02 billion in revenue each year. The medical technology company earns $248.50 million in net income (profit) each year or $3.72 on an earnings per share basis.

How many employees does Hill-Rom have?

The company employs 10,000 workers across the globe.

How can I contact Hill-Rom?

Hill-Rom's mailing address is 130 East Randolph Street Suite 1000, Chicago IL, 60601. The official website for the company is www.hill-rom.com. The medical technology company can be reached via phone at (312) 819-7200, via email at marykay.ladone@hill-rom.com, or via fax at 812-934-8189.

This page (NYSE:HRC) was last updated on 12/1/2022 by MarketBeat.com Staff